Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: David Jones who wrote (1665)	10/2/1998 10:52:00 AM
From: Joe	Read Replies (1) \| Respond to of 4140

David, Again, the approval process is as follows: 1) Conduct clinicals. 2) Submit clinical data in a PMA to FDA. (mid-11/98 est.) 3) Ophthalmic Devices Panel meets and reviews the PMA. (3/99 est.) 4) Panel recommends approval, approval with conditions, or disapproval to FDA. 5) FDA approves in a month or two after that, asks for more data and approves after it is submitted, or disaproves the PMA. 7) When FDA approves, then SNRS starts selling product in the U.S.A. Cool. Joe